Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation-Reply.
The functional performance status during weekdays and weekends in persons with multiple sclerosis.
Design, synthesis and docking studies of novel 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents.
Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy.
Current Evidence Does Not Support Exercise Therapy for Perceived Fatigue in Multiple Sclerosis.
Proteolytic regulation of synaptic plasticity in the mouse primary visual cortex: analysis of matrix metalloproteinase 9 deficient mice.
Protective effects of BMP-7 against tumor necrosis factor α-induced oligodendrocyte apoptosis.
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
Population PK-PD Analyses of CD25 Occupancy, CD56(bright) NK Cell Expansion, and Regulatory T Cell Reduction by Daclizumab HYP in Subjects with Multiple Sclerosis.
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.
White Matter and Cognition: Making the Connection.
Microglia response in retina and optic nerve in chronic experimental autoimmune encephalomyelitis.
Encephalomyelitis Associated With Dengue Fever.
Constipation prevalence in multiple sclerosis about a cohort of 81 patients.
Recombinant Antibody Fragments For Neurodegenerative Diseases.
Adipose stromal vascular fraction-mediated improvements at late-stage disease in a murine model of multiple sclerosis.
Acute transverse myelitis of the cervical spine secondary to psoas abscess.
Bilateral abducens nerve palsy in an infant case of fulminant acute disseminated encephalomyelitis: a case report.
Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices.
The proteome of normal human retrobulbar optic nerve and sclera.
Aquaporin 4 Antibody in the Korean Patient with New-Onset Optic Neuritis.
Heterogeneous anisotropic magnetic susceptibility of the myelin-water layers causes local magnetic field perturbations in axons.
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
Pages
« first
‹ previous
…
806
807
808
809
810
811
812
813
814
…
next ›
last »